Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01180777 · ClinicalTrials.gov registry record · NA

Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)

A NA study, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
95
Enrollment target

NCT01180777: Completed NA study, sponsored by Johnson & Johnson Vision Care.

NCT01180777 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 95 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01180777, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the lens fit (mechanical and cosmetic lens fit) of the printed etafilcon A with polyvinylpyrrolidone (PVP).

Primary Outcome

Lens fit acceptance (whether acceptable or unacceptable) was assessed by the Investigator at dispensing.

Interventions

  • DEVICE etafilcon A (A)
  • DEVICE etafilcon A (B)
  • DEVICE etafilcon A (C)

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2010-07-01
Est. Completion 2010-08-01
Phase NA
Johnson & Johnson Vision Care

142 total trials

What the finished NCT01180777 record still lists

NCT01180777 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 3 interventions - of which etafilcon A (A) is the first listed.

NCT01180777 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01180777 about?

NCT01180777 is a clinical study titled "Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)". The purpose of this study is to evaluate the lens fit (mechanical and cosmetic lens fit) of the printed etafilcon A with polyvinylpyrrolidone (PVP).

What is the current status of trial NCT01180777?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2010-07-01. Estimated completion is 2010-08-01.

What interventions are being tested in trial NCT01180777?

The interventions under investigation include: etafilcon A (A) (DEVICE), etafilcon A (B) (DEVICE), etafilcon A (C) (DEVICE).

Who is sponsoring clinical trial NCT01180777?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01180777's enrollment target sits among peer trials

95 931st of 2000 higher than 1,066 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04206215 · 95 participants · NA

    Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01180777, the US trial registry maintained by the National Library of Medicine. NCT01180777 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.